← back to search

Mingjun Wang

Jiamusi University · CN
Area of research
Oncology · Immunology
Research interest
Research interests include Immunotherapy and Immune Responses, CAR-T cell therapy research, vaccines and immunoinformatics approaches, and Rheumatoid Arthritis Research and Therapies.
h-index
37
citations
4,330
works
267
NIH funding
primary concept
email

Recent publications

CAR-T cell therapy based on a TCR mimic nanobody targeting an intracellular antigen for solid cancers.
2025cited by 0position: contributordoi
Current advances in cancer vaccines targeting NY-ESO-1 for solid cancer treatment.
2023cited by 26position: contributordoi
Phase 3, long-term, open-label extension period of safety and efficacy of belimumab in patients with systemic lupus erythematosus in China, for up to 6 years
RMD Open 2022cited by 17position: middledoi
Rapid identification of tumor-reactive T-cell receptors by RNA preamplification-based single-cell sequencing.
2022cited by 1position: contributordoi
Identification and assessment of TCR-T cells targeting an epitope conserved in SARS-CoV-2 variants for the treatment of COVID-19.
2022cited by 1position: contributordoi
Microbiota regulate innate immune signaling and protective immunity against cancer
Cell Host & Microbe 2021cited by 160position: middledoi
A Correlation Between Differentiation Phenotypes of Infused T Cells and Anti-Cancer Immunotherapy.
2021cited by 21position: contributordoi
Large-Scale Identification of T-Cell Epitopes Derived From Severe Acute Respiratory Syndrome Coronavirus 2 for the Development of Peptide Vaccines Against Coronavirus Disease 2019.
2021cited by 6position: contributordoi
Benefits of Chimeric Antigen Receptor T-Cell Therapy for B-Cell Lymphoma.
2021cited by 5position: contributordoi
Next Generation Sequencing-Based Identification of T-Cell Receptors for Immunotherapy Against Hepatocellular Carcinoma.
2021cited by 3position: contributordoi
An efficient method to identify virus-specific TCRs for TCR-T cell immunotherapy against virus-associated malignancies.
2021cited by 2position: contributordoi
Phenotypic analysis of tumor-infiltrating lymphocytes from non-small cell lung cancer and their potential application for adoptive cell therapy.
2020cited by 5position: contributordoi
Cancer immunotherapy with lymphocytes genetically engineered with T cell receptors for solid cancers.
2019cited by 11position: contributordoi
Expression of New York esophageal squamous cell carcinoma 1 and its association with Foxp3 and indoleamine-2,3-dioxygenase in microenvironment of nonsmall cell lung cancer.
2019cited by 4position: contributordoi
Rheumatoid arthritis–associated DNA methylation sites in peripheral blood mononuclear cells
Annals of the Rheumatic Diseases 2018cited by 134position: middledoi
Analysis of test results of urinary hydroxyproline and c- terminal telopeptide of collagen type II concentrations among Kashin-Beck disease patients in Qinghai plateau
Chin J Endemiol 2018cited by 0position: middledoi
LRRC25 Functions as an Inhibitor of NF-κB Signaling Pathway by Promoting p65/RelA for Autophagic Degradation
Scientific Reports 2017cited by 77position: middledoi
Integrative multi-omics analysis revealed SNP-lncRNA-mRNA (SLM) networks in human peripheral blood mononuclear cells
Human Genetics 2017cited by 17position: middledoi
Study on the correlation between Ras related sequence family 2A gene methylation and colorectal cancer in feces
Zhonghua shiyan waike zazhi 2017cited by 0position: middledoi
Cross-Regulation of Two Type I Interferon Signaling Pathways in Plasmacytoid Dendritic Cells Controls Anti-malaria Immunity and Host Mortality
Immunity 2016cited by 120position: middledoi
TAK1 Negatively Regulates NF-κB and p38 MAP Kinase Activation in Gr-1+CD11b+ Neutrophils
Immunity 2012cited by 159position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Rong‐Fu Wang · University of Southern California4 papers (2012–2021)Helen Y. Wang · University of Southern California3 papers (2012–2021)Xiang Lin · Nanchang University2 papers (2017–2018)Xin Lu · Sun Yat-sen University Cancer Center2 papers (2017–2018)Yufan Guo · South China Agricultural University2 papers (2017–2018)Morten Nielsen · Technical University of Denmark2 papers (2021–2022)Yinghua Qiu · University Health Network2 papers (2017–2018)Xiao Yu · Huazhong Agricultural University2 papers (2016–2021)Jun Cui · Xinjiang Medical University2 papers (2012–2017)Yaozhong Liu · Shandong University2 papers (2017–2018)Xingbo Mo · Soochow University2 papers (2017–2018)Xiaowei Zhu · Sun Yat-sen University2 papers (2017–2018)Adebusola Alagbala Ajibade · Houston Methodist2 papers (2012–2021)Peng Tan · Houston Methodist2 papers (2016–2021)Changsheng Xing · The University of Texas MD Anderson Cancer Center2 papers (2016–2021)Jian Wu · Nantong University2 papers (2017–2018)Shu‐Feng Lei · University of Alabama at Birmingham2 papers (2017–2018)Long‐Fei Wu · Guangdong University of Technology2 papers (2017–2018)Fei‐Yan Deng · Tulane University2 papers (2017–2018)Nengjun Yi · University of Alabama at Birmingham2 papers (2017–2018)